Bosatria News
Most Popular Bosatria Story
Glaxo pulls its EU app for rare disease therapy
GlaxoSmithKline says it reluctantly decided to pull its EU application for Bosatria (mepolizumab) after concluding that it didn't have the kind of efficacy data needed to make its case that the drug Read more...
Latest Headlines
- July 29, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
